Video description If you have ADHD and you’re taking, considering, or hearing about medications like Ozempic, Wegovy, or Mounjaro, there’s one unexpected effect people keep talking about: less food noise, fewer cravings, and sometimes feeling more focused. In this video, I take a closer look at what people with ADHD are actually reporting, what current research says about GLP-1 receptor agonists, reward, cravings, addiction, and brain function, and where the evidence still falls short. GLP-1 medications are not approved treatments for ADHD, and we do not currently have convincing clinical evidence that they directly treat core ADHD symptoms. But that doesn’t mean the experiences people are reporting are meaningless. People are describing things like: - quieter mental noise - fewer intrusive thoughts about food - reduced cravings - improved task initiation - better focus - less sensory seeking - less impulsive behavior So what could be going on? Researchers are increasingly studying GLP-1 medications for effects beyond blood sugar and weight loss, including their potential influence on reward pathways, cravings, substance use, and cognition. I also look at the well-documented relationship between ADHD and obesity, and why improvements in things like eating patterns, metabolic health, sleep, and daily routines could potentially affect how ADHD feels in everyday life. And because lived experience matters, I also share several real-world reports from people with ADHD taking GLP-1 medications. The goal of this video is not to tell anyone to take a GLP-1 for ADHD. It is to ask a much more interesting question: If people with ADHD are repeatedly describing similar changes, what should researchers be looking at next? Research discussed De Giorgi R, et al. GLP-1 receptor agonists in cognitive and mental health disorders Nature Mental Health, 2025 DOI: 10.1038/s44220-025-00390-x GLP-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes The BMJ, 2026;392 DOI: 10.1136/bmj-2025-086886 Randomized controlled research on semaglutide and alcohol use disorder is also discussed, along with broader research into GLP-1 signaling, reward, and appetite regulation. If you take a GLP-1 medication and also have ADHD, I’d really like to hear your experience. Did you notice any change in: food noise? focus? impulsivity? motivation? sensory seeking? task initiation? Share what changed, if anything, in the comments. This channel is about lived ADHD experience, community, and the research that may help us better understand what we feel. You’re not broken. You’re not alone. You’re just human. 0:00 Unexpected benefits for focus 1:05 What the research says about cravings 3:29 The complex relationship with obesity 4:49 Real stories from the community #ADHD #GLP1 #Ozempic #Mounjaro #Wegovy #AdultADHD #ADHDResearch #ADHDMedication